"hepatocellular cancer" trang 3 - tải miễn phí từ tailieuXANH
GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis

GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis
8    53    0
Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
9    53    0
Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma

Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
10    60    0
Epigenetic silencing of glutaminase 2 in human liver and colon cancers

Epigenetic silencing of glutaminase 2 in human liver and colon cancers
9    68    0
MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells

MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells
9    64    0
Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma

Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma
8    53    0
Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: An in vitro and in vivo study

Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: An in vitro and in vivo study
10    73    0
Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
11    52    0
Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma

Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma
9    62    0
Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma

Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma
16    51    1
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
11    390    1
Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: A retrospective cohort study

Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: A retrospective cohort study
13    174    1
MARCH6 promotes hepatocellular carcinoma development through upregulation of ATF2

MARCH6 promotes hepatocellular carcinoma development through upregulation of ATF2
11    111    1
Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: A pilot study

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: A pilot study
12    61    1
Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin

Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin
17    354    1
The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: Basing on competing risk model

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: Basing on competing risk model
9    19    1
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signalling

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signalling
9    21    1
A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells

A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells
18    18    1
A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy

A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy
12    123    1
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
10    15    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.